CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
Why Patients Drop Out And How To Stop Them
From scheduling friction to silent financial stress, patient dropout derails trials. Here’s what’s causing it and the tech helping sites fight back.
-
Predictive Analytics Is Reshaping How Sponsors Run Clinical Trials
Predictive analytics is transforming clinical trial operations, from enrollment forecasting to risk-based monitoring. Here’s what sponsors need to know.
ECOA RESOURCES
-
Explore how the use of electronic Clinical Outcomes Assessments (eCOAs) can be rapidly implemented to capture patient reported outcomes (PROs).
-
This ebook describes how electronic clinical outcomes assessments (eCOA), mobile digital assessments, and other innovative data capture technologies are able to “meet patients where they are” in Parkinson’s Disease trials – with increasingly objective, sensitive, and continuous measures.
-
Enhance hybrid trials with digitalization through remote data capture using smartphones, tablets, and computers, improving participant experience and data integrity.
ECONSENT RESOURCES
-
Learn how eConsent digitalizes the trial participant consent process through increasingly simplified models designed to improve comprehension and boost engagement.
-
In this case study, discover how a company was pointed to an electronic data capture (EDC) system that was quick to adapt and easy to scale as the study changed.
-
Understand the gaps between how data is collected in real-world evidence (RWE) and randomized clinical trials (RCT) and how RWE is quickly finding ways to catch up.
EPRO RESOURCES
-
Learn how eConsent digitalizes the trial participant consent process through increasingly simplified models designed to improve comprehension and boost engagement.
-
In this blog, explore how the approach to PROs needs to be reconsidered, given increasing regulations and trial scrutiny, the clinical need for patient-reported outcomes, and the ability to drive costs down and move off paper.
-
The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.